171.19 0.00 (0.00%)
After hours: 4:00PM EDT
|Bid||161.56 x 300|
|Ask||181.46 x 500|
|Day's Range||171.19 - 175.91|
|52 Week Range||147.58 - 181.67|
|PE Ratio (TTM)||9.96|
|Expense Ratio (net)||0.25%|
After negotiating on two versions of the bill already passed by the House and Senate, Republicans unveiled their final tax bill — which would reshape the tax code in three decades, making America more competitive. The Congress will vote on the legislation on Tuesday and sent it to President Donald Trump for his signature by the end of the year.Source: Shutterstock
The Zacks Analyst Blog Highlights: Vanguard Small-Cap Growth, iShares S&P Small-Cap 600 Growth and Vanguard S&P Small-Cap 600 Growth
Small-capitalization stock investors were defensive going into the 2017, but they have quickly changed their tune, turning to more growth-weighted smaller company picks. Investors can also gain diversified ...
Eli Lilly’s (LLY) Captisol-enabled drug Prexasertib is currently being evaluated in multiple oncology indications such as head and neck cancer, small-cell lung cancer (or SCLC), and advanced metastatic ...
Ligand Pharmaceuticals (LGND) expects its licensees to invest ~$2.0 billion for advancing more than 155 partnered research and development programs in 2017.
At a time when the U.S. small-cap stocks and exchange traded funds, such as the iShares Core S&P Small-Cap ETF (NYSEArca: IJR) and the iShares Russell 2000 ETF (NYSEArca: IWM) , are trailing large-cap ...